Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

218 results
Display

Real Life Data of Treat and Extend Intravitreal Ranibizumab and Aflibercept Therapy in Wet Age-related Macular Degeneration Patients: 3-Year Results

Ugurtay O, Kockar A, Sengul EA

Purpose: To compare functional and anatomic outcome of intravitreal ranibizumab (IVR) and intravitreal aflibercept (IVA) treatments in neovascular age-related macular degeneration by using the treat and extend (TE) protocol. Methods: In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy

Park MS, Lee SJ

Purpose: We examined differences in the treatment effects of intravitreal bevacizumab injections and intravitreal aflibercept injections in patients with central serous chorioretinopathy. Methods: This retrospective analysis included 51 eyes of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Efficacy of Intravitreal Dexamethasone Implant in Korean Patients with Non-infectious Uveitis

Han JY, Lee DH, Kim JD, Choi EY, Kim M

Purpose: To evaluate the therapeutic efficacy and safety of intravitreal dexamethasone implant in non-infectious uveitis (divided into anterior, intermediate, posterior, and panuveitis types). Methods: The medical records of patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical Management of Complications after Dexamethasone Implant Injection

Kim SH, Choi Y, Choi SK, Lee JJ, Byon IS, Lee JE, Park SW

Purpose: To report complications requiring surgical management related to intravitreal dexamethasone implant. Methods: The medical records of patients who received intravitreal dexamethasone implant injection from June 2013 to March 2020 were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Influencing on Vision-related Quality of Life in Patients with Retinal Diseases Receiving Intravitreal Injections

Kim H, Ha Y

Purpose: The purpose of this study was to identify influencing factors on vision-related quality of life in patients with retinal diseases receiving intravitreal injections by examining relationships among anxiety, depression,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity

Kwon JM, Pak KY, Lee JJ, Sagong M, Kim HW

Purpose: To evaluate the one-year efficacy of intravitreal aflibercept injection in polypoidal choroidal vasculopathy (PCV) with best-corrected visual acuity (BCVA) of 20 / 40 or better. Methods: This was a multicenter...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ocular Pain According to Needle Diameter during Intravitreal Injection

Lee SK, Kim WH, Kim SJ, Park JS

Purpose: To compare the ocular pain scores and injection times of patients during 30 and 40-gauge intravitreal injection procedures. Methods: This study was performed prospectively in patients who had not previously...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prospective Clinical Trial of Intravitreal Aflibercept Treat-andextend Regimen for Diabetic Macular Edema: 1-Year Outcomes

Mieno H, Yoneda K, Terao N, Yoshii K, Kojima K, Nagata K, Sotozono C

Purpose: To investigate the efficacy of aflibercept for the treatment of diabetic macular edema via a treat-and-extend regimen. Methods: This prospective, single-center, open-label, interventional study involved 30 patients with a best-corrected...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Topical Antibiotic Prophylaxis on Conjunctival Flora and Antibiotic Resistance Following Intravitreal Injections in Patients with Type 2 Diabetes

Kaldirim H, Yazgan S, Kirgiz A, Ozdemir B, Yilmaz A

Purpose: We sought to determine changes in the conjunctival bacterial flora and antibiotic resistance after topical antibiotic drops for infection prophylaxis were administered following intravitreal injections in patients with type...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema

Kaldırım H, Savur F, Kırgız A, Atalay K

Purpose: To compare the effectiveness of dexamethasone (DEX) intravitreal implants for the treatment of diabetic macular edema between phakic and pseudophakic eyes after a follow-up. Methods: A total of 79 eyes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Intravitreal Dexamethasone Implant for Diabetic Macular Edema According to Previous Responses to Bevacizumab

Kim D, Park DG, Ryu G, Sagong M

PURPOSE: To compare the efficacy of intravitreal dexamethasone implants according to previous response to bevacizumab treatment in patients with diabetic macular edema (DME). METHODS: Forty-nine eyes of 49 patients who received...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fulminant Toxoplasmic Chorioretinitis Following Intravitreal Dexamethasone Implantation

Jeong A, Park DG, Sagong M

PURPOSE: To report a case of fulminant toxoplasmic chorioretinitis following intravitreal dexamethasone implantation monotherapy in a stabilized toxoplasmic chorioretinitis patient with initial treatment. CASE SUMMARY: A 60-year-old healthy female presented with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Epiretinal Membrane on Dexamethasone Implant for Branch Retinal Vein Occlusion Macular Edema

Jang M, Kim JY, Lee SY, Jeong JH, Lee EK

PURPOSE: To evaluate the effect of epiretinal membrane (ERM) on the outcomes of intravitreal dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) treatment for macular edema (ME) secondary to branch retinal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration

Cho S, Shin SJ, Suh JK, Tchoe H, Kang MJ, Yang J, Jee D

PURPOSE: To evaluate the current use of intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) in patients with age-related macular degeneration (AMD). METHODS: We analyzed the number and medical costs of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review

Kang MJ, Shin SJ, Suh JK, Cho S, Tchoe H, Yang J, Jee D

PURPOSE: To compare the efficacy and safety of intravitreal injections of bevacizumab, ranibizumab, and aflibercept for the treatment of new patients with age-related macular degeneration (AMD). METHODS: We conducted an update...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity

Kang HG, Kim TY, Han J, Han SH

PURPOSE: To compare long-term refractive outcomes associated with intravitreal anti-vascular endothelial growth factor (VEGF) versus laser photocoagulation treatment for retinopathy of prematurity (ROP). METHODS: A total of 52 eyes from 27...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review

Park KH, Kim YY, Jo YJ, Oh J, Lee JE, Lee JE, Park DH, Kang SW, Lee WK, Kim HK, Adena M, Tan J, Kim SD

BACKGROUND: Limited data exist on real-world treatment patterns for diabetic macular edema (DME) in Korea. In this study, we investigated DME treatment patterns from 2009 to 2014 and the impact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept

Moon TK, Ha JY, Sung MS, Park SW

PURPOSE: To evaluate long-term intraocular pressure (IOP) and risk of IOP elevation after intravitreal injection of ranibizumab or aflibercept in patients with age-related macular degeneration (AMD). METHODS: From January 2013 to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of a Post-vitrectomy Injection of N-methyl-N-nitrosourea as a Localized Retinal Degeneration Rabbit Model

Ahn SM, Ahn J, Cha S, Yun C, Park TK, Goo YS, Kim SW

Since genetic models for retinal degeneration (RD) in animals larger than rodents have not been firmly established to date, we sought in the present study to develop a new rabbit...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary to Optic Nerve Head Drusen

Park KH

PURPOSE: To describe a patient with optic nerve head drusen who showed improved retinal hemorrhage and visual acuity following intravitreal anti-vascular endothelial growth factor (bevacizumab) injection. CASE SUMMARY: A 53-year-old woman...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr